Thematics Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$8.14M Buy
83,346
+7,268
+10% +$753K 0.37% 82
2025
Q2
$8.17M Sell
76,078
-1,818
-2% -$184K 0.37% 82
2025
Q1
$7.86M Sell
77,896
-29,908
-28% -$3.01M 0.4% 78
2024
Q4
$9.63M Buy
107,804
+2,328
+2% +$205K 0.42% 82
2024
Q3
$8.84M Buy
105,476
+10,778
+11% +$850K 0.35% 90
2024
Q2
$7.29M Hold
94,698
0.3% 97
2024
Q1
$6.49M Buy
94,698
+6,800
+8% +$437K 0.27% 102
2023
Q4
$5.08M Buy
87,898
+2,584
+3% +$138K 0.22% 113
2023
Q3
$4.5M Buy
+85,314
New +$4.47M 0.22% 118

Other funds holding BSX

Thematics Asset Management's BSX Position: Q3 2025 in Review

Thematics Asset Management increased its Boston Scientific (BSX) stake by 9.6% in Q3 2025, buying an estimated $753K and bringing the position to 83,346 shares worth $8.14M. The position accounts for 0.37% of the portfolio, ranked #82.

Thematics Asset Management first reported a position in BSX in Q3 2023 and has held it in 9 quarters since. The position peaked at $9.63M in Q4 2024. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Thematics Asset Management held 83,346 shares of Boston Scientific worth $8.14M as of Q3 2025.
  • Thematics Asset Management bought 7,268 Boston Scientific shares in Q3 2025, an estimated $753K.
  • Boston Scientific made up 0.37% of Thematics Asset Management's portfolio in Q3 2025, its #82 holding.
  • Thematics Asset Management first reported a position in Boston Scientific in Q3 2023 and has held it in 9 quarters since.
  • Thematics Asset Management's Boston Scientific position peaked at $9.63M in Q4 2024.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Thematics Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.